Substance
RITONAVIR
Global reference: every product and company linked to this substance.
- cas: 155213-67-5
- ncit: C1609
- pubchem_cid: 392622
- rxnorm: 85762
- unii: O3J8G9O825
A-84538 · ABBOTT-84538 · ABT-538 · EMPETUS · NORVIR · NSC-693184 · PAXLOVID COMPONENT RITONAVIR · RITOMUNE · ritonavir [INN] · RITONAVIR [JAN] · RITONAVIR [USAN] · Ritonavir [WHO-DD]
Revenue by product (4)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ABBVIE INC. COMMON STOCK | KALETRA | Q1 2020 | $86.0M* |
| PFIZER INC. COMMON STOCK | PAXLOVID (COPACKAGED) | Q2 2026 | $21.0M* |
| ABBVIE INC. COMMON STOCK | VIEKIRA PAK (COPACKAGED) | Q1 2020 | $5.0M* |
| ABBVIE INC. COMMON STOCK | VIEKIRA XR | Q1 2020 | $5.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (10)
- ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE · VIATRIS INC. COMMON STOCK
- KALETRA · ABBVIE INC. COMMON STOCK
- LOPINAVIR AND RITONAVIR · VIATRIS INC. COMMON STOCK
- LOPINAVIR; RITONAVIR · VIATRIS INC. COMMON STOCK
- NORVIR · ABBVIE INC. COMMON STOCK
- PAXLOVID (COPACKAGED) · PFIZER INC. COMMON STOCK
- RITONAVIR · AMNEAL PHARMACEUTICALS INC. CLASS A COMMON STOCK
- TECHNIVIE · ABBVIE INC. COMMON STOCK
- VIEKIRA PAK (COPACKAGED) · ABBVIE INC. COMMON STOCK
- VIEKIRA XR · ABBVIE INC. COMMON STOCK